Citius holds webinar series on conducting mino-lok phase 3 trial during covid-19

Cranford, n.j., dec. 15, 2020 /prnewswire/ -- citius pharmaceuticals, inc. ("citius" or the "company") (nasdaq: ctxr), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, today announced that it has conducted a series of webinars to...

CTXR Ratings Summary

CTXR Quant Ranking